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Association of the Intestinal 
Microbiome with the Development 
of Neovascular Age-Related 
Macular Degeneration
Martin S. Zinkernagel1,2,*, Denise C. Zysset-Burri1,2,*, Irene Keller2,3, Lieselotte E. Berger1, 
Alexander B. Leichtle4, Carlo R. Largiadèr4, Georg M. Fiedler4 & Sebastian Wolf1,2
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the elderly. 
There is evidence that nutrition, inflammation and genetic risk factors play an important role in the 
development of AMD. Recent studies suggest that the composition of the intestinal microbiome 
is associated with metabolic diseases through modulation of inflammation and host metabolism. 
To investigate whether compositional and functional alterations of the intestinal microbiome are 
associated with AMD, we sequenced the gut metagenomes of patients with AMD and controls. The 
genera Anaerotruncus and Oscillibacter as well as Ruminococcus torques and Eubacterium ventriosum 
were relatively enriched in patients with AMD, whereas Bacteroides eggerthii was enriched in controls. 
Patient’s intestinal microbiomes were enriched in genes of the L-alanine fermentation, glutamate 
degradation and arginine biosynthesis pathways and decreased in genes of the fatty acid elongation 
pathway. These findings suggest that modifications in the intestinal microbiome are associated with 
AMD, inferring that this common sight threatening disease may be targeted by microbiome-altering 
interventions.
Age-related macular degeneration (AMD; Fig. 1a) is the leading cause of severe visual impairment in the elderly 
population of industrialized countries. AMD has become a significant global health issue1, and the prevalence of 
AMD is projected to grow by 50 percent in the next decades2. It is a complex disease that is caused by a combina-
tion of environmental and genetic factors. Several studies have shown that diet is a major modifiable risk factor 
for AMD development3–8. Intestinal microbial organisms and their genomes, collectively termed microbiome, 
play a major role in the digestion of food and in this way influence the global metabolism of their host9. The 
intestinal microbiome forms a complex ecosystem of up to 100 trillion microbes and shows substantial diversity 
of gut communities among individuals10. However, changes in microbiome composition can potentially modulate 
or alternatively stress host metabolism and may act as sources of inflammation and disease11. Recent findings 
have identified the intestinal microbiome as a contributor to metabolic diseases such as atherosclerosis, which is 
associated with lipid accumulation and inflammation in the arterial wall12. Furthermore, a recent report has sug-
gested that the intestinal microbiome may trigger autoimmune response in the eye through activation signals to 
retina specific T cells13. Given the link between AMD and diet, the composition of the intestinal microbiome may 
also influence AMD development and progression. This link has recently been substantiated in an animal model, 
where alterations in the intestinal microbiome have resulted in exacerabation of choroidal neovascularization, 
a hallmark of neovascular AMD14. Neovascular AMD is caused by choroidal neovascularization, which often 
results in exudation and hemorrhage, leading to photoreceptor damage and central visual loss.
To address this issue, we investigated whether compositional and functional diversity of the intestinal micro-
biome is associated with AMD development and progression. To this end, we sequenced the intestinal metage-
nomes of patients with recent onset neovascular AMD and age- and sex-matched controls without AMD. For 
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profiling microbial communities, we used the Metagenomic Phylogenetic Analysis (MetaPhlAn) tool15 and 
to infer the metabolic potential of the identified microbes, the HMP (Human Microbiome Project16) Unified 
Metabolic Analysis Network (HUMAnN)17 was applied. The data revealed an enrichment of Oscillibacter, 
Anaerotruncus, Eubacterium ventriosum and Ruminococcus torques in AMD patients versus Bacteroides eggerthii 
in controls. Our findings may have important implications for the prevention of this sight threatening disease as 
the intestinal microbiome may be modified by probiotics and antibiotics.
Figure 1. Disease phenotype and bioinformatics pipeline. (a) Representative color photographs and 
optical coherence tomography (OCT) images of a patient with neovascular age-related macular degeneration 
(AMD; left) and an age-matched control (right). (b) Illustration of our bioinformatics pipeline for analysing 
metagenomic data and its relation to neovascular AMD. Sequencing reads from stool probes were generated 
with high throughput sequencing and subjected to quality control. Species abundances were estimated by 
alignment of high quality reads to clade-specific marker sequences using the Metagenomic Phylogenetic 
Analysis (MetaPhlAn) tool. To describe the functional profile of the intestinal microbiome, the HMP (Human 
Microbiome Project) Unified Metabolic Analysis Network (HUMAnN) was used. The linear discriminant 
analysis (LDA) effect size (LEfSe) algorithm was applied to identify features significantly different between 
patients and controls. To provide a global analysis of microbial species and pathway abundance principal 
component analysis (PCA) using ade4 were performed.
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Results
Taxonomic characterization of the intestinal microbiome. To address whether the intestinal micro-
biome is associated with neovascular AMD, we sequenced the gut metagenomes of 12 patients with recent 
onset signs of neovascularization due to AMD and 11 age- and sex-matched controls without any signs of AMD 
(Table 1). In total, we generated 557 million 100 bp paired-end reads with an average insert size of 350 bp (on 
average, 24 ± 0.1 (s.d.) million reads per sample).
After trimming and filtering (see Methods), we obtained about 20 million non-human high-quality reads 
per sample for further analysis. On average, 4.6 ± 1.2% (s.d.) of the reads of a sample could be aligned to any 
marker sequence. This is by a factor of ten less than described in previous metagenomic studies using Illumina 
reads12,18. This discrepancy is due to the fact that MetaPhlAn maps reads against a catalogue of marker sequences 
including about 4% of the sequenced microbial genomes15. The majority of mapped reads were bacterial 
(99.2 ± 1.6% in patients and 99.7 ± 0.5% (s.d.) in controls). The microbiome composition was dominated by the 
phyla Bacteriodetes (65.3 ± 16.5% in AMD and 74.7 ± 12.6% (s.d.) in controls) and Firmicutes (29.0 ± 14.4% in 
AMD and 20.4 ± 8.9% (s.d.) in controls), followed by Actinobacteria (2.1 ± 3.2% in AMD and 1.6 ± 3.6% (s.d.) 
in controls) and Proteobacteria (1.6 ± 1.7% in AMD and 2.4 ± 3.0% (s.d.) in controls). Bacteroidia (65.3 ± 16.5% 
in AMD and 74.7 ± 12.6% (s.d.) in controls) and Clostridia (27.1 ± 13.4% in AMD and 19.4 ± 8.8% (s.d.) in 
controls) were shown to be the most abundant classes in our cohort (Fig. 2). This composition is consistent 
with previous observations12,19,20. The genera Bacteroides (36.5 ± 14.6% in AMD and 40.8 ± 23.1% (s.d.) in con-
trols) and Alistipes (12.6 ± 6.4% in AMD and 13.8 ± 11.9% (s.d.) in controls) dominated the microbiome, fol-
lowed by Eubacterium with a high intersubject variation (8.9 ± 8.6% in AMD and 5.3 ± 6.9% (s.d.) in controls). 
A total of 12 species were detected in all 23 samples, making up the core microbiome in our cohort, in agree-
ment with previous observations18. Bacteroides uniformis was the most abundant species with 8.7 ± 6.0% in AMD 
and 6.1 ± 5.7% (s.d.) in controls, followed by Alistipes onderdonkii (4.4 ± 4.7% in AMD and 7.4 ± 10.5% (s.d.) in 
Feature Patients (n = 12) Controls (n = 11) P value AMD vs C
Males (n) 8 7 1Δ
Age (years) 78.4 ± 7.4 72.5 ± 7.0 0.064*
Current smoker (n) 1 0 1Δ
Previous smoker (n) 6 5 1Δ
BMI (kg/m2) 27.5 ± 4.8 25.5 ± 4.6 0.31*
Table 1. Characteristics of study participants. AMD, age-related macular degeneration; BMI, body mass 
index; C, control. Data are mean ± SD, ΔFisher’s exact t test, *Welch’s t test.
Figure 2. Taxonomic characterization of the intestinal microbiome using MetaPhlAn. Mean relative 
abundance of the major microbial classes among individuals of the cohort. Red are patients (age-related 
macular degeneration (AMD), n = 12), green are controls (n = 11).
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controls), Subdoligranulum species (4.8 ± 3.9% in AMD and 4.4 ± 6.1% (s.d.) in controls) and Alistipes putredinis 
(4.8 ± 4.6% in AMD and 4.1 ± 3.9% (s.d.) in controls).
Distinct microbial composition. A principal component analysis with the health status as grouping 
variable revealed that differences in abundance of microbial species separated the patient group from the con-
trol group (Fig. 3a). To identify the taxa differing in relative abundance between AMD and controls, LEfSe was 
applied on the previously identified microbiome. The genera Anaerotruncus and Oscillibacter (and the family 
Figure 3. Microbial composition associated with neovascular age-related macular degeneration (AMD). 
(a) Principal component analysis of microbial species abundance using health status as grouping variable. 
The relation between microbial abundance and health status was assessed using Monte Carlo simulations 
with 10,000 iterations by which a p value was calculated. (b,c) Identification of taxonomic features relevant in 
neovascular AMD using LefSe. Cladogram for taxonomic representation of significant differences among AMD 
and controls. The diameter of each circle is proportional to its abundance (b). Histogram of the LDA scores 
for differentially abundant taxonomic features among groups. The threshold on the logarithmic LDA (linear 
discriminant analysis) score for discriminative features was set to 2.0 (C). (d) Box plots representing the mean 
abundance + /− SD of bacterial genera and species associated with AMD (Kruksal-Wallis test, p ≤ 0.05). Red are 
patients (AMD, n = 12), green are controls (C, n = 11).
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Oscillospiraceae) as well as Ruminococcus torques and Eubacterium ventriosum were enriched in AMD, whereas 
Bacteroides eggerthii was enriched in controls (p < 0.05, Kruksal-Wallis test; Fig. 3b,c).
Metabolic functions of altered intestinal microbiome. To describe the metabolic features of the 
microbiome, we applied HUMAnN on each sample separately based on the taxonomic profiles from MetaPhlAn. 
Resulting organism-specific gene hits were functionally assigned to pathways using MinPath and their rela-
tive abundances were assessed. From the totally 2193 assigned organism-specific pathways, 253 pathways were 
detected in all samples making up the core metabolic functions in our cohort. A principal component analysis 
with the health status as grouping variable revealed that the difference in abundance of metabolic pathways sep-
arated the patient group from the control group (Fig. 4a). Applying LEfSe, 20 abundant pathways (i.e. occurring 
in at least 11 samples) were identified that differ between AMD patients and controls (Fig. 4b). Based on the 
distribution of pathway abundances in each sample with empiric p values > 0.05, we identified four differentially 
abundant pathways (Fig. 4c) using an empiric null distribution. L-alanine fermentation (GO 0019652), glutamate 
degradation (GO 0019671) and arginine biosynthesis (GO 0006525) pathways were up-regulated in the intestinal 
microbiome of AMD patients, whereas fatty acid elongation pathway (GO 00062) was enriched in the microbi-
ome of controls (see Supplementary Fig. S1).
Discussion
In this study, we identified several compositional and functional variations of the intestinal microbiome that may 
be related to the development of neovascular AMD. There is significant geographic and ethnic variability in the 
prevalence of AMD2. Although genetic susceptibility has been shown to play a substantial role in the pathogenesis 
of AMD and may contribute to the ethnic differences in its prevalence21, this variability may be further influenced 
by differences in the intestinal microbiome and diet, respectively. The intestinal microbiome consists of a complex 
community of microbes that impact normal physiology and susceptibility to disease mediated by inflammatory 
molecules such as lipopolysaccharides and peptidoglycans, which may contribute to metabolic disease22,23. The 
intestinal microbiome landscape seems to be fairly distinct and temporally stable in each individual. This sug-
gests that a stable equilibrium exists for the microbiome. Furthermore, twins have more comparable microbiome 
compositions than unrelated individuals, suggesting that genetics may influence the microbiome composition. 
On the other hand, environmental factors may have a similar impact on microbiome composition, as monozy-
gotic and dizygotic adult twins have equally similar microbiomes11. Recent studies have shown that the European 
microbiome is dominated by the Bacteroides enterotype, whereas the African microbiome was dominated by the 
Prevotella enterotype24.
We observed associations between neovascular AMD and microbiome composition at the taxonomical levels 
of bacterial genera and species. Furthermore, principal component analysis (PCA) on microbial species abun-
dance confirmed a separation of patients and controls by microbiome composition (Fig. 3a). First, the relative 
abundance of Bacteroides eggerthii was increased in healthy age- and sex-matched controls. Bacteroides genera 
have been shown to play a major role in carbohydrate fermentation resulting in a pool of volatile fatty acids that 
are reabsorbed through the intestinal mucosa, providing a significant source of energy to the host25. Bacteroides 
can produce polysaccharide A (PSA), which may be involved in ligand-receptor interaction, modulating the 
immune response to pathogens. It has been indeed shown that PSA derived from Bacteroides spp. protect from 
experimental autoimmune encephalitis26. Secondly, the relative abundances of species such as Ruminococcus tor-
ques, a gram positive bacterium with mucin degradation capacities and Oscillibacter, which has been associated 
with high fat diet27, were increased in AMD patients. An increased Oscillibacter population has been shown to 
result in an increased gut permeability presumably mediated by a reduction in the mRNA expression tight junc-
tions including ZO-128. An increased relative abundance of Anaerotruncus species has been associated with aging 
and age-associated inflammation with elevated pro-inflammatory chemokines in a mouse model29. A similar 
finding has been reported for Eubacterium ventriosum spp. in humans which has been associated with elevated 
IL-6 and IL-8 cytokine levels30.
High-fat diets have been shown to exacerbate choroidal neovascularization in a mouse model by increasing 
the relative abundance of Firmicutes. These findings were associated with heightened intestinal permeability 
and chronic low-grade inflammation with elevated production of IL-6, IL-1b, TNF-a, and VEGF-A, cytokines 
that have been associated with the development of neovascular AMD14. A similar shift of relative abundance in 
Firmicutes at the expense of Bacteroidetes was observed in our cohort, with a relative abundance of Firmicutes of 
29.0% in AMD and 20.4% in the control group.
Functional annotation analyses indicated that specific genes involved in individual metabolic pathways are 
enriched or decreased in patients with neovascular AMD. Although these genes allow to identify associated path-
ways and therefore can predict functional capabilities, quantification of messenger RNA and metabolic profiling 
to confirm functional differences are needed to further confirm these associations.
However, PCA on gene and pathway abundance revealed a separation of patients and controls by functional 
features (Fig. 4a). Our data revealed a decline in bacteria responsible for fatty acid elongation and an increase in 
L-alanine fermentation, glutamate degradation and arginine biosynthesis in patients with neovascular AMD. In 
the last decade, it has become evident that nutritional factors may influence the progression of AMD. A recent 
study has observed a decrease of some n-3 very long chain polyunsaturated fatty acids in the retina of eyes with 
early and intermediate AMD31. As such bioavailability of long chain polyunsaturated fatty acids is likely to have 
an impact on retinal physiology and may contribute to AMD. Glutamate is the main excitatory neurotransmitter 
in the retina and decreased availability of glutamate has been shown to result in deficient neurotransmission in 
the retina32. Furthermore, in patients with reduced ornithin aminotransferase activity increased levels of arginine 
are associated with progressive chorioretinal atrophy, suggesting an important role for arginine in the develop-
ment of retinal degeneration33.
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The best-validated supplementation therapy for AMD is the age-related eye disease study (AREDS) formu-
lation, which contains antioxidant vitamin C and vitamin E, beta-carotene, copper and zinc. This combination 
has been shown to reduce risk toward progression of advanced AMD34. The bioavailability of several of these 
components may be influenced by the microbiome composition. This is supported by the large effect of the 
Figure 4. Species-specific microbial pathways associated with neovascular age-related macular 
degeneration (AMD). (a) Principal component analysis of microbial pathway abundance with health status as 
instrumental variable. The relation between pathway abundance and health status was assessed using Monte 
Carlo simulations with 10,000 iterations by which a p value was calculated. (b) Metabolic pathways that are 
differentially abundant among subjects with AMD and controls, ranked according to the effect size (LDA 
score, linear discriminant analysis score). (c) Box plots representing the mean abundance + /− SD of pathways 
associated with AMD (empiric p > 0.05). Red is patients (AMD, n = 12), green is controls (C, n = 11).
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microbiome on mammalian plasma biochemistry which has been demonstrated by comparing plasma extracts 
from germ-free mice with samples from conventional mice35. Importantly, generation of certain antioxidants 
such as indole-3-propionic acid was shown to be completely dependent on the presence of intestinal microflora. 
Furthermore, it has been suggested that zinc absorption may be influenced by zinc competition between micro-
biome in the gastrointestinal tract of a host36.
This study cannot provide evidence for direct causal effects of an altered intestinal microbiome on the devel-
opment of neovascular AMD. Study limitations are the small sample size which may not represent the entire 
AMD population, and furthermore, there are possible confounders due to genetic background and nutritional 
habit of patients and controls. However, if a specific taxonomic group or a metagenomic cluster annotated to a 
specific metabolic pathway is ultimately shown to be causally related to neovascular AMD, then long-term dietary 
interventions may allow modulation of an individual’s microbiome to avoid disease. The interplay between micro-
biome and the innate immune system, e.g. the complement system may provide a link between host genome and 
microbiome and remains an area of active investigation.
Our study suggests that the intestinal microbiome may play an important role in the development of neovas-
cular AMD and may constitute a link between nutrition and development of this common disease.
Methods
Study design and recruitment. Participants (n = 23) were recruited from the Department of 
Ophthalmology of the University Hospital Bern (Inselspital), Switzerland. This study was conducted in 
accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Canton of Bern 
(ClinicalTrials.gov: NCT02438111). After receiving oral and written information, all participants gave writ-
ten informed consent to participate in the study. All participants were subjected to an ophthalmic examination 
including standard fundus color photography and optical coherence tomography. Patients (n = 12) had clinically 
confirmed recent onset of neovascular AMD and were 50 years of age or older. The control group (n = 11) was 
selected to represent an age- and sex-matched group with no signs of AMD. We tested for differences in a range 
of demographic values between the two groups using either Welch’s t test (for age and BMI) or Fisher’s exact test 
(for gender and smoking) in R v.3.2.137. Further exclusion criteria for both groups were problems with the bowel 
movement, chronic inflammatory and gastrointestinal disease (including previous surgery in the gastrointestinal 
tract), recent history of use of systemic antibiotics within the last three months and opacities of ocular media.
Sequencing and data quality control. Stool samples were brought chilled to the study center where they 
were immediately processed and frozen at − 20 °C. Metagenomic DNA was isolated from 0.25 g of stool sample 
using the PowerSoil® DNA Isolation kit (Mo Bio Laboratories, Carlsbad, USA) according to the manufactur-
er’s protocol. The DNA was sent to BGI Europe (Copenhagen N, Denmark) for paired-end shotgun sequencing 
with up to ten samples pooled in one lane using the Illumina HiSeq 2000 platform. For library preparation, 
purified DNA was sheared by nebulization. The resulting overhangs were converted into blunt ends using T4 
DNA polymerase, Klenow Fragment and T4 Polynucleotide kinase. After adding an ‘A’ base to the 3′ end of the 
blunt phosphorylated DNA fragments, adapter ligation was performed. Too short fragments were removed with 
Ampure beads and the resulting library was used for sequencing following standard pipelines of the Illumina plat-
form, generating 100 bp paired-end reads. The reads were quality filtered with Trimmomatic v.0.32 as follows38: 
Illumina adapter sequences were removed and read ends were clipped off if the average base quality in a 4 bp win-
dow slid along the length of the read dropped below 15. We retained only reads of at least 80 bp after trimming. To 
remove sequences of human origin, all reads were mapped to the human reference genome hg19 using Bowtie2 
v.2.2.439 and only the unmapped reads were used for further analysis.
Taxonomical analysis. The bioinformatics pipeline used for analysing the metagenomic data is illustrated 
in Fig. 1b. For microbial profiling, the high-quality non-human reads were mapped against a set of clade-specific 
markers (spanning bacteria and archaea at the species level or higher) using the Metagenomic Phylogenetic 
Analysis (MetaPhlAn) tool v.2.0 and the marker database v.2015 using default settings. In order to provide the 
relative abundance of each taxonomic unit, Bowtie2 v.2.2.4 was used for alignment (option “very-sensitive”) fol-
lowed by normalization of the total number of reads in each clade by the nucleotide length of its marker.
The R package ade440 performing PCA was used to provide the global analysis of microbial species 
abundances between AMD and controls as described in http://www.sthda.com/english/wiki/ade4-and- 
factoextra-principal-component-analysis-r-software-and-data-mining. PCA was performed with scaled values 
on relative abundances of microbial species identified by MetaPhlAn (Fig. 1b). A visualization of the individual 
samples grouped by the classes (case and control) is provided in Fig. 3a. Monte Carlo simulations with 10,000 
iterations were performed on the between-groups inertia percentage by which a p value was calculated in Fig. 3a.
To identify taxa with significantly different relative abundances in AMD and controls, relative abundances 
from the different samples were merged and the linear discriminant analysis effect size (LEfSe) algorithm41 was 
applied with default settings (p < 0.05 based on Kruksal-Wallis test and LDA score ≥ 2).
Functional profiling. To describe the metabolic potential of the identified microbes, the HMP (Human 
Microbiome Project)16 Unified Metabolic Analysis Network (HUMAnN2 v.0.2.1) was used with default settings17. 
HUMAnN investigates the presence/absence and the relative abundance of gene families and pathways in each 
sample to provide a functional interpretation of the metagenomic sequences. HUMAnN was run for each sample 
separately using the taxonomic profiles from MetaPhlAn. For nucleotide-level searches, Bowtie2 v.2.2.4 was used 
to map reads to the functionally annotated pangenome database ChocoPhlAn. All unmapped reads were used 
for translated searches against the universal protein reference database UniRef5042 using Diamond v. 0.7.943. 
The resulting organism-specific gene hits were assigned to pathways using MinPath v.1.244, finally providing a 
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set of pathways and their relative abundances. To provide an empiric null distribution, 10,000 permutations were 
performed, randomly assigning the pathways to the two groups, and for each permutation the difference of the 
means was calculated, providing an empiric p value for each feature (Fig. 4c).
The R package ade440 performing PCAwas used to provide the global analysis of pathway abundance 
between AMD and controls as described in http://www.sthda.com/english/wiki/ade4-and-factoextra- 
principal-component-analysis-r-software-and-data-mining. PCA was performed with scaled values on relative 
abundance of genes and pathways identified by HUMAnN (Fig. 1b). A visualization of the individuals grouped 
by case and control is provided in Fig. 4a. Monte Carlo simulations with 10,000 iterations were performed on the 
between-groups inertia percentage by which a p value was calculated in Fig. 4a.
To identify differences between AMD and controls, LEfSe was applied to all pathways that had been found 
in at least 11 of the 23 samples using default settings. A difference was considered to be statistically significant if 
p < 0.05 (Kruksal-Wallis test) and LDA score ≥ 2.
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